|
H2AC11 expression profile based on
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| ER negative-vs-ER positive | 4.98914259728248E-07
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| HER2 Negative-vs-HER2 Positive | 8.84160572314228E-06
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Insitu-vs-Invasive | 4.481500E-01 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Non-TNBC tumors-vs-TNBC tumors | <1E-12 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| PR Negative-vs-PR Positive | 6.82431769523454E-12
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Ki67 Low-vs-Ki67 High | 1.09656644332986E-33
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Lymph Node Negative-vs-Lymph Node Positive | 7.252166E-03 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Grade 1-vs-Grade 2 |
1.57800793139316E-06 |
| Grade 1-vs-Grade 3 |
3.41148459810149E-50 |
| Grade 2-vs-Grade 3 |
2.57762917982952E-39 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| 21-40yrs-vs-41-60yrs |
3.050185E-04 |
| 21-40yrs-vs-61-80yrs |
2.78960755352375E-08 |
| 21-40yrs-vs-81-100yrs |
3.07857918328967E-06 |
| 41-60yrs-vs-61-80yrs |
3.07665688878045E-06 |
| 41-60yrs-vs-81-100yrs |
1.690695E-02 |
| 61-80yrs-vs-81-100yrs |
5.269892E-01 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| T1-vs-T2 |
1.18664028161582E-07 |
| T1-vs-T3 |
4.834403E-01 |
| T1-vs-T4 |
8.934444E-02 |
| T1-vs-Tis |
7.836943E-01 |
| T2-vs-T3 |
2.065219E-03 |
| T2-vs-T4 |
3.574389E-01 |
| T2-vs-Tis |
8.932815E-02 |
| T3-vs-T4 |
6.637138E-02 |
| T3-vs-Tis |
9.148739E-01 |
| T4-vs-Tis |
1.008771E-01 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal like-vs-LumA |
1.804824E-01 |
| Normal like-vs-LumB |
8.0350327825929E-31 |
| Normal like-vs-HER2 enriched |
4.67238814236478E-22 |
| Normal like-vs-Basal like |
1.4054405079639E-14 |
| LumA-vs-LumB |
3.84644423950565E-39 |
| LumA-vs-HER2 enriched |
3.8475012066566E-23 |
| LumA-vs-Basal like |
1.03761737185173E-18 |
| LumB-vs-HER2 enriched |
2.738862E-01 |
| LumB-vs-Basal like |
8.61993635291277E-07 |
| HER2 enriched-vs-Basal like |
2.01626955545149E-06 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Ductal-vs-Lobular |
2.49350130732311E-60 |
| Ductal-vs-Ductal_Lobular |
3.593530E-04 |
| Ductal-vs-Ductal_Other |
5.610959E-01 |
| Ductal-vs-Other |
3.096683E-01 |
| Lobular-vs-Ductal_Lobular |
5.438761E-02 |
| Lobular-vs-Ductal_Other |
5.105438E-03 |
| Lobular-vs-Other |
1.70775767497454E-11 |
| Ductal_Lobular-vs-Ductal_Other |
1.504643E-01 |
| Ductal_Lobular-vs-Other |
6.758814E-04 |
| Ductal_Other-vs-Other |
3.053087E-01 |
|
|
